Glutamate receptor ionotropic, kainate 1 (GRIK1) (GRIK1)

Glutamate receptor ionotropic, kainate 1 (GRIK1), also known as GluK1, is a protein that functions as a ligand-gated ion channel and belongs to the kainate receptor subclass of ionotropic glutamate receptors [1][2]. It is primarily expressed in the central nervous system, particularly in the hippocampus, cortex, and dorsal horn of the spinal cord, where it plays a critical role in excitatory neurotransmission and the modulation of synaptic plasticity [2][3]. GRIK1 acts both postsynaptically to mediate excitatory currents and presynaptically to regulate the release of other neurotransmitters like GABA and glutamate [3]. Due to its role in regulating neuronal excitability, GRIK1 is a significant therapeutic target for conditions characterized by hyperexcitability or altered signaling, such as epilepsy, migraine, and chronic neuropathic pain [4][5]. Research has also identified GRIK1 as a genetic risk factor and potential target for substance use disorders, particularly alcohol dependence [6]. Pharmacological agents targeting GRIK1 include selective antagonists designed to suppress pain or seizure activity without the widespread side effects associated with broader glutamate receptor inhibition [5][6]. However, clinical development faces challenges regarding the balance between therapeutic efficacy and central nervous system-related side effects [4].

Other names

GluK1GLUR5EAA3Excitatory amino acid receptor 3Glutamate receptor 5

Competitive or non-competitive antagonism to reduce glutamate-mediated hyperexcitability and modulate presynaptic neurotransmitter release [1][5].